Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2523 Target Snapshot

Disintegrin and metalloproteinase domain-containing protein 17 · SINGLE PROTEIN · Rattus norvegicus

9Compounds
6Assays
0Approved Drugs
8.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9Z1K9. Use UniProt Q9Z1K9 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Z1K9 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Disintegrin and metalloproteinase domain-containing protein 17 as ChEMBL target CHEMBL2523, mapped to UniProt Q9Z1K9. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Disintegrin and metalloproteinase domain-containing protein 17
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2523
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9Z1K9
Disintegrin and metalloproteinase domain-containing protein 17
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Disintegrin and metalloproteinase domain-containing protein 17 is the right protein anchor across sources, using UniProt Q9Z1K9 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDisintegrin and metalloproteinase domain-containing protein 17
UniProt AccessionQ9Z1K9
Component TypeProtein
Sequence Length827 aa

Disintegrin and metalloproteinase domain-containing protein 17

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Disintegrin and metalloproteinase domain-containing protein 17, mapped to UniProt Q9Z1K9. Sequence length is 827 aa.

Mapped IDQ9Z1K9
Review nameDisintegrin and metalloproteinase domain-containing protein 17
OrganismRattus norvegicus
Assay Mix

Activity Type Distribution

IC508.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL435102 8.77 IC50 1.7 Preclinical
CHEMBL363126 8.0 IC50 10.0 Preclinical
CHEMBL185168 7.96 IC50 11.0 Preclinical
CHEMBL183995 7.85 IC50 14.0 Preclinical
CHEMBL365283 7.82 IC50 15.0 Preclinical
CHEMBL365658 7.75 IC50 18.0 Preclinical
CHEMBL364643 7.64 IC50 23.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
0
6.0
0
6.5
0
7.0
6
7.5
1
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

6
Total Assays
7
Tested Compounds
2
Assay Types
Functional — 5 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 4 0
cell-free format 1 0
Binding — 1 assays, 7 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 7 8.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine